Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Blood Transcriptomic Signal According to Coronary Atherosclerotic Plaque Burden Assessed by CT Angiography: CORPLAQ-TRAIT Pilot Study

NCT06194526 is registered in ClinicalTrials.gov with MultiplAI Health Limited as lead sponsor.

NCT NCT06194526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06194526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Blood Transcriptomic Signal According to Coronary Atherosclerotic Plaque Burden Assessed by CT Angiography: CORPLAQ-TRAIT Pilot Study
Lead sponsor
MultiplAI Health Limited
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 19, 2023
Completion date
September 30, 2028
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aortic calcification, atherosclerotic plaque, calcific coronary arteriosclerosis, coronary plaque, coronary stenosis